C型肝炎検査の世界市場レポート2025年

C型肝炎検査市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.2％で、16億8,000万米ドルに成長します。予測期間の成長は、疾患の早期発見に対する需要の増加、ヘルスケアへのアクセス拡大、予防医療への重点化、世界の医療機関からの支援、C型肝炎撲滅を目指した政府の取り組みなどに起因しています。この期間に予想される主な動向には、マルチプレックス診断プラットフォームの採用、診断ツールへの人工知能（AI）の組み込み、在宅検査キットへの移行、検査開発における協力体制の強化、手頃な価格の検査ソリューションの創出などがあります。

肝炎患者の有病率の増加は、C型肝炎検査市場の今後の成長を促進すると予想されます。C型肝炎は、肝臓に炎症を引き起こすウイルス感染症であり、治療を受けなければ深刻な肝障害を引き起こす可能性があります。肝炎患者の増加は、ワクチン接種率が低いことが主な原因であり、多くの人々が脆弱な状態に置かれ、ウイルスが蔓延しています。C型肝炎検査は、ウイルスの早期発見を可能にし、肝障害や重篤な合併症を防ぐためのタイムリーな治療を可能にします。また、感染者を特定することで感染を抑制し、疾病管理を改善することができます。例えば、スイスに本部を置く世界保健機関（WHO）は2024年4月、世界で5,000万人以上がC型慢性肝炎に感染しており、毎年約100万人が新たに感染していると報告しました。このように、肝炎患者の増加は、C型肝炎検査市場の成長に拍車をかけています。

C型肝炎検査市場の主要企業は、感染のスクリーニングとモニタリングを改善するために、二重抗原抗体診断検査のような先進的ソリューションの開発に注力しています。これらの検査では、ウイルスタンパク質（抗原）と免疫応答タンパク質（抗体）が検出されるため、活動中の感染と過去の感染の両方を特定することができます。この二重検出法により、感染状態を包括的に評価することができます。例えば、2023年7月、インドを拠点とする診断検査およびシステムのプロバイダーであるRoche Diagnostics India Pvt. Ltd.は、単一の血漿または血清サンプルからHCV抗原と抗体の両方を同時に独立して検出する完全自動免疫測定法であるElecsys HCV Duoを発売しました。この革新的な技術により、早期診断が容易になり、患者管理を支援するとともに、適時かつ徹底したスクリーニングによりC型肝炎を撲滅するというインドの国家目標をサポートします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のC型肝炎検査：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のC型肝炎検査市場：成長率分析
• 世界のC型肝炎検査市場の実績：規模と成長, 2019-2024
• 世界のC型肝炎検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界のC型肝炎検査：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のC型肝炎検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗体検査
• 核酸検査
• 遺伝子型検査
• 世界のC型肝炎検査市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 検査キット
• 機器
• 試薬
• 消耗品
• 世界のC型肝炎検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素免疫測定（ELISA）
• 迅速診断検査
• ポリメラーゼ連鎖反応
• 次世代シーケンシング
• 世界のC型肝炎検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液スクリーニング
• ウイルス量モニタリング
• 病気の診断
• 世界のC型肝炎検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院併設の検査室
• 独立型ラボ
• その他のエンドユーザー
• 世界のC型肝炎検査市場抗体検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素免疫測定（EIA）
• 組み換え免疫ブロットアッセイ（RIBA）
• 迅速診断検査（RDT）
• 世界のC型肝炎検査市場核酸検査（NAT）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定量リボ核酸（RNA）検査
• 定性リボ核酸（RNA）検査
• 転写介在増幅（TMA）
• 逆転写ポリメラーゼ連鎖反応（RT-PCR）
• 世界のC型肝炎検査市場、遺伝子型検査の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラインプローブアッセイ（LiPA）
• シーケンシングベースのアッセイ
• リアルタイムポリメラーゼ連鎖反応（PCR）に基づく遺伝子型判定

第7章 地域別・国別分析

• 世界のC型肝炎検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のC型肝炎検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• C型肝炎検査市場：競合情勢
• C型肝炎検査市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Quest Diagnostics Incorporated
• Hologic Inc.
• QuidelOrtho Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• SD Biosensor INC.
• QIAGEN N.V.
• DiaSorin S.p.A.
• Cepheid
• Abcam Plc
• OraSure Technologies Inc.
• Meridian Bioscience Inc.
• Trivitron Healthcare Private Limited
• General Biologicals Corporation
• Biogate Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• C型肝炎検査市場2029：新たな機会を提供する国
• C型肝炎検査市場2029：新たな機会を提供するセグメント
• C型肝炎検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hepatitis C testing involves diagnostic techniques used to detect HCV infection or the body's immune response to it. These tests identify both current and past infections, enabling timely treatment. They are especially important for high-risk individuals and assist in monitoring treatment effectiveness. Early diagnosis helps reduce the risk of serious liver complications like cirrhosis and liver cancer.

The primary types of hepatitis C testing include antibody tests, nucleic acid tests, and genotyping tests. Antibody tests detect antibodies in the blood, indicating either a past or ongoing immune response to infections such as hepatitis C. The testing products encompass kits, instruments, reagents, and consumables that utilize various technologies like enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests, polymerase chain reaction (PCR), and next-generation sequencing (NGS). These tests are used in applications such as blood screening, viral load monitoring, and disease diagnosis, and serve end-users including hospital laboratories, stand-alone labs, and others.

The hepatitis C testing market research report is one of a series of new reports from The Business Research Company that provides hepatitis C testing market statistics, including the hepatitis C testing industry global market size, regional shares, competitors with the hepatitis C testing market share, detailed hepatitis C testing market segments, market trends, opportunities, and any further data you may need to thrive in the hepatitis C testing industry. This hepatitis C testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hepatitis C testing market size has grown strongly in recent years. It will grow from $1.24 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth during the historic period can be credited to the increasing prevalence of hepatitis C, the expansion of public health initiatives, a rise in intravenous drug use, heightened awareness of hepatitis C risks, and increased government funding for infectious disease control.

The hepatitis C testing market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the increasing demand for early disease detection, expanded access to healthcare, a stronger focus on preventive healthcare, support from global health organizations, and government initiatives aimed at hepatitis C elimination. Key trends expected during this period include the adoption of multiplex diagnostic platforms, incorporation of artificial intelligence (AI) in diagnostic tools, a move toward home-based testing kits, enhanced collaboration in test development, and the creation of affordable testing solutions.

The increasing prevalence of hepatitis cases is expected to drive the growth of the hepatitis C testing market moving forward. Hepatitis C is a viral infection that causes liver inflammation and can result in severe liver damage if untreated. The rise in hepatitis cases is largely due to low vaccination rates, leaving many people vulnerable and enabling the virus to spread. Hepatitis C testing enables early detection of the virus, allowing timely treatment to prevent liver damage and serious complications. It also helps identify infected individuals to curb transmission and improve disease management. For example, in April 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental agency responsible for global public health, reported that over 50 million people worldwide are living with chronic hepatitis C infection, with roughly 1.0 million new cases annually. Thus, the increasing prevalence of hepatitis cases is fueling the growth of the hepatitis C testing market.

Leading companies in the hepatitis C testing market are focusing on developing advanced solutions like dual antigen-antibody diagnostic tests to improve screening and monitoring of the infection. These tests detect viral proteins (antigens) as well as immune response proteins (antibodies), allowing identification of both active and past infections. This dual detection method provides a comprehensive assessment of infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based provider of diagnostic tests and systems, launched Elecsys HCV Duo-a fully automated immunoassay that simultaneously and independently detects both HCV antigens and antibodies from a single plasma or serum sample. This innovation facilitates early diagnosis, aids patient management, and supports India's national goal to eliminate hepatitis C through timely and thorough screening.

In June 2022, Liver Care Canada, a healthcare organization focused on liver disease management, partnered with HepCURE Inc. to eliminate hepatitis C in Canada by 2030. This collaboration seeks to incorporate HepCURE's hepatitis C screening and treatment programs into Liver Care Canada's services, aiming to improve medication adherence, enhance patient outcomes, and increase access to care in underserved communities. HepCURE Inc., a Canadian non-profit organization dedicated to hepatitis C diagnosis and treatment, has demonstrated a 91% diagnosis rate and 80% linkage to care in Vancouver with its model.

Major players in the hepatitis C testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, and BIOGENIX INC. PVT. LTD.

North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hepatitis C testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hepatitis C testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hepatitis C testing market consists of revenues earned by entities by providing services such as laboratory-based HCV RNA testing, rapid diagnostic tests, and home-based HCV test kits. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis C testing market also includes sales of quality control materials, sample collection devices, and point-of-care (POC) diagnostic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hepatitis C Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hepatitis c testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hepatitis c testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hepatitis c testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Antibody Tests; Nucleic Acid Tests; Genotyping Tests
• 2) By Product: Test Kits; Instruments; Reagents; Consumables
• 3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Diagnostic Tests; Polymerase Chain Reaction; Next-Generation Sequencing
• 4) By Application: Blood Screening; Viral Load Monitoring; Disease Diagnosis
• 5) By End-User: Hospital-Based Laboratories; Stand-Alone Laboratories; Other End-Users
• Subsegments:
• 1) By Antibody Tests: Enzyme Immunoassay (EIA); Recombinant Immunoblot Assay (RIBA); Rapid Diagnostic Tests (RDTs)
• 2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests; Qualitative Ribonucleic Acid (RNA) Tests; Transcription-Mediated Amplification (TMA); Reverse Transcription Polymerase Chain Reaction (RT-PCR)
• 3) By Genotyping Tests: Line Probe Assay (LiPA); Sequencing-Based Assay; Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hepatitis C Testing Market Characteristics

3. Hepatitis C Testing Market Trends And Strategies

4. Hepatitis C Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hepatitis C Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hepatitis C Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hepatitis C Testing Market Growth Rate Analysis
• 5.4. Global Hepatitis C Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hepatitis C Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hepatitis C Testing Total Addressable Market (TAM)

6. Hepatitis C Testing Market Segmentation

• 6.1. Global Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody Tests
• Nucleic Acid Tests
• Genotyping Tests
• 6.2. Global Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Test Kits
• Instruments
• Reagents
• Consumables
• 6.3. Global Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests
• Polymerase Chain Reaction
• Next-Generation Sequencing
• 6.4. Global Hepatitis C Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Screening
• Viral Load Monitoring
• Disease Diagnosis
• 6.5. Global Hepatitis C Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital-Based Laboratories
• Stand-Alone Laboratories
• Other End-Users
• 6.6. Global Hepatitis C Testing Market, Sub-Segmentation Of Antibody Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme Immunoassay (EIA)
• Recombinant Immunoblot Assay (RIBA)
• Rapid Diagnostic Tests (RDTs)
• 6.7. Global Hepatitis C Testing Market, Sub-Segmentation Of Nucleic Acid Tests (NATs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Quantitative Ribonucleic Acid (RNA) Tests
• Qualitative Ribonucleic Acid (RNA) Tests
• Transcription-Mediated Amplification (TMA)
• Reverse Transcription Polymerase Chain Reaction (RT-PCR)
• 6.8. Global Hepatitis C Testing Market, Sub-Segmentation Of Genotyping Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Line Probe Assay (LiPA)
• Sequencing-Based Assay
• Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

7. Hepatitis C Testing Market Regional And Country Analysis

• 7.1. Global Hepatitis C Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hepatitis C Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hepatitis C Testing Market

• 8.1. Asia-Pacific Hepatitis C Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hepatitis C Testing Market

• 9.1. China Hepatitis C Testing Market Overview
• 9.2. China Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hepatitis C Testing Market

• 10.1. India Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hepatitis C Testing Market

• 11.1. Japan Hepatitis C Testing Market Overview
• 11.2. Japan Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hepatitis C Testing Market

• 12.1. Australia Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hepatitis C Testing Market

• 13.1. Indonesia Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hepatitis C Testing Market

• 14.1. South Korea Hepatitis C Testing Market Overview
• 14.2. South Korea Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hepatitis C Testing Market

• 15.1. Western Europe Hepatitis C Testing Market Overview
• 15.2. Western Europe Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hepatitis C Testing Market

• 16.1. UK Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hepatitis C Testing Market

• 17.1. Germany Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hepatitis C Testing Market

• 18.1. France Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hepatitis C Testing Market

• 19.1. Italy Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hepatitis C Testing Market

• 20.1. Spain Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hepatitis C Testing Market

• 21.1. Eastern Europe Hepatitis C Testing Market Overview
• 21.2. Eastern Europe Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hepatitis C Testing Market

• 22.1. Russia Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hepatitis C Testing Market

• 23.1. North America Hepatitis C Testing Market Overview
• 23.2. North America Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hepatitis C Testing Market

• 24.1. USA Hepatitis C Testing Market Overview
• 24.2. USA Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hepatitis C Testing Market

• 25.1. Canada Hepatitis C Testing Market Overview
• 25.2. Canada Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hepatitis C Testing Market

• 26.1. South America Hepatitis C Testing Market Overview
• 26.2. South America Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hepatitis C Testing Market

• 27.1. Brazil Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hepatitis C Testing Market

• 28.1. Middle East Hepatitis C Testing Market Overview
• 28.2. Middle East Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hepatitis C Testing Market

• 29.1. Africa Hepatitis C Testing Market Overview
• 29.2. Africa Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hepatitis C Testing Market Competitive Landscape And Company Profiles

• 30.1. Hepatitis C Testing Market Competitive Landscape
• 30.2. Hepatitis C Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Hepatitis C Testing Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Incorporated
• 31.2. Hologic Inc.
• 31.3. QuidelOrtho Corporation
• 31.4. Sysmex Corporation
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. SD Biosensor INC.
• 31.7. QIAGEN N.V.
• 31.8. DiaSorin S.p.A.
• 31.9. Cepheid
• 31.10. Abcam Plc
• 31.11. OraSure Technologies Inc.
• 31.12. Meridian Bioscience Inc.
• 31.13. Trivitron Healthcare Private Limited
• 31.14. General Biologicals Corporation
• 31.15. Biogate Laboratories Ltd.

32. Global Hepatitis C Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hepatitis C Testing Market

34. Recent Developments In The Hepatitis C Testing Market

35. Hepatitis C Testing Market High Potential Countries, Segments and Strategies

• 35.1 Hepatitis C Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hepatitis C Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hepatitis C Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer